Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Interleukin-6 Biology Takes Center Stage
-
- Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis
- Researchers Identify Metabolite Disturbances in Patients With Chronic Fatigue Syndrome
- Postoperative Articular Cartilage and Subchondral Bone Imaging
- Five News Items From the American Society for Bone and Mineral Research Annual Meeting
- FDA Approves Amjevita, Biosimilar to Humira
- Ilaris Receives Three Simultaneous FDA Approvals for Periodic Fever Syndromes
- Johnson & Johnson Announces Ruling Related to its Infliximab Biosimilar
- Potential Biosimilar to Infliximab From Pfizer Demonstrated Efficacy Similar to Remicade
-
- IL-6 Returns to Center Stage: Are the New Agents on the Horizon the Same or Different?
- The Patient With Back Pain
- AAP Urges Restrictions on Use of Codeine in Children
- HHS Sets Final Rule on Registering Clinical Trials, Submitting Results
- Atherosclerosis Risk Higher in Sjögren’s Syndrome Patients With Low ABI, Positive Antibodies
- Early Life Intervention May Prevent Knee OA Later in Life
- Greater Wound Healing, Renal Complications Found Among TJA Patients With Gout
- Ixekizumab Improved Disease Activity, Physical Function in Patients With Psoriatic Arthritis
-
- Similar Efficacy Seen Between Tocilizumab as Monotherapy vs Combination Therapy
- Call to Action Seeks to Address ‘Crisis’ in Treatment of Osteoporosis
- Romosozumab Reduced New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- Preliminary Study Indicates Possible Connection Between Chronic Pain and Weather Conditions
- Young Patient Age, Rheumatoid Arthritis Diagnosis in TKA Require Special Attention